Evidence map›Paper›PMID 41913066›Full record

ReviewClinical pharmacology and therapeutics2026

Community Partnerships in Clinical Research: A Framework for Sustainability and Resilience.

Shayna R Killam, Bernie Azure, C Brenda Bodnar, Vernon Finley, Marissa Rose Grant, Patricia Kelly, Karen E Brown, Erica L Woodahl

Abstract readReview
In one paragraph

Review in Clinical pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shayna R KillamL.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.ORCID 0009-0006-7288-5196
Bernie AzureConfederated Salish and Kootenai Tribes, Community Pharmacogenomics Advisory Council, Pablo, Montana, USA.
C Brenda BodnarConfederated Salish and Kootenai Tribes, Community Pharmacogenomics Advisory Council, Pablo, Montana, USA.
Vernon FinleyConfederated Salish and Kootenai Tribes, Community Pharmacogenomics Advisory Council, Pablo, Montana, USA.
Marissa Rose GrantConfederated Salish and Kootenai Tribes, Community Pharmacogenomics Advisory Council, Pablo, Montana, USA.
Patricia KellyConfederated Salish and Kootenai Tribes, Community Pharmacogenomics Advisory Council, Pablo, Montana, USA.
Karen E BrownL.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.ORCID 0000-0002-9866-3237
Erica L WoodahlL.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.ORCID 0000-0002-0413-4140

Funding

Pharmacogenetics in Rural and Underserved PopulationsU01GM092676 · NIGMS · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., THUMMEL, KENNETH E. · 2010 to 2014
$9.9M
Vitamin K gene network: Variant discovery and characterizationP01GM116691 · NIGMS · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G. · 2016 to 2020
$7.6M
Pharmacogenomic approaches to drug metabolism in American Indian/Alaska Native PeopleR35HG011319 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI CLAW, KATRINA G · 2020 to 2024
$2.9M
Community-engaged Research Toward Precision Medicine with AIAN PeopleR01HG009500 · NHGRI · UNIVERSITY OF ALASKA FAIRBANKS · PI BOYER, BERT BRANDON, DILLARD, DENISE A · 2017 to 2019
$2.0M
Ensuring Equity in Pharmacogenetics for Rural and Underserved CommunitiesF32HG013895 · NHGRI · UNIVERSITY OF MONTANA · PI Shayna Rae Killam · 2024 to 2026
$160k
NHGRI NIH HHS F32 HG013895NHGRI NIH HHS R01 HG009500NHGRI NIH HHS R35 HG011319NIGMS NIH HHS P01 GM116691NIGMS NIH HHS U01 GM092676
6 · The paper itself

Abstract

Variable health outcomes across populations remain chronic challenges in modern healthcare, due in part to an imbalance in participation in clinical research. Rather than base novel therapeutics on narrow cohorts that limit validity and generalizability, we should broaden our commitments to developing solutions that benefit all populations. Many participants remain hesitant due to mistrust in research and medical institutions; however, novel approaches are necessary to bridge the gap in research representation. These concerns are particularly prominent in Indigenous communities, which have faced a long history of unethical research practices. Community-based participatory research methods can aid researchers in improving research access by centering community engagement at the core of the research partnership and enabling co-creation of research priorities. We have created a community-academic partnership with an Indigenous community in Montana over almost two decades, built on mutual respect and learning. Drawing on our partnership, we present community-engaged strategies that together form a framework for building meaningful, enduring community partnerships that foster trust in research. This framework can help to ensure that clinical research opportunities are more broadly available, supporting the diffusion of health innovations to every patient.

Indexed as

Biomedical ResearchCommunity-Based Participatory ResearchCommunity-Institutional RelationsAcademiaCooperative BehaviorHumansMontanaTrust

Identifiers

PMID41913066
PMCPMC13580197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.